2Shen GJ.Activity of Qinghaosu and its derivatives against Schistosoma[].Chin J Parasitic Disease Control.1997 被引量:1
3Yang DM,Liew FY.Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis[].Parasitology.1993 被引量:1
4Fulton JP.The separation of Leishmania infantum amastigotes[].Transactions of the Royal Society of Tropical Medicine and Hygiene.1949 被引量:1
5Melby PC,Yang J,Zhao W,et al.Leishmania infantum p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis[].Infection and Immunity.2001 被引量:1
6White NJ.Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives[].Transactions of the Royal Society of Tropical Medicine and Hygiene.1994 被引量:1
7Janse CJ,Waters AP,Kos J,et al.Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model[].International Journal for Parasitology.1994 被引量:1
8Berman JD.Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years[].Clinical Infectious Diseases.1997 被引量:1
9Marty P,Rosenthal E.Treatment of visceral leishmaniasis: a review of current treatment practices[].Expert Opinion on Pharmacotherapy.2002 被引量:1